Michael F Maclean Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Michael F Maclean has an estimated net worth of at least $19.3 million*, as of Oct. 29, 2025. They own shares of RNA stock. They have sold 409,721 shares of RNA stock since 2021, for an estimated $14.7 million.
Michael F Maclean $RNA SEC Form 4 Insider Trading
Michael F Maclean has filed a total of 17 insider trades in $RNA since 2021. Their most recent trade was a sale of 1,807 shares, made on Jan 21, 2026. Their largest trade was a sale of 104,245 shares, made on Jun 12, 2024. We estimate that they now own shares of $RNA, worth an estimated $4.6 million.
Insider Trading at $RNA
There have been a total of 160 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.9 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Michael F Maclean, and Teresa Mccarthy. The most recent trade was a sale of 2,878 shares reported by Steven George Hughes (Chief Medical Officer), made on Jan 21, 2026.
History of Insider Stock Trades by Michael F Maclean
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
RNA
|
Sale | 1,807 | Jan 21, 2026 | Jan. 23, 2026, 6:33 p.m. |
|
RNA
|
Sale | 2,735 | Jan 21, 2026 | Jan. 23, 2026, 6:33 p.m. |
|
RNA
|
Sale | 1,974 | Jan 07, 2026 | Jan. 9, 2026, 6:12 p.m. |
|
RNA
|
Sale | 30,914 | Aug 06, 2025 | Aug. 15, 2025, 4:09 p.m. |
|
RNA
|
Sale | 7,935 | Mar 20, 2025 | March 21, 2025, 6:38 p.m. |
|
RNA
|
Sale | 1,665 | Jan 21, 2025 | Jan. 23, 2025, 9:15 p.m. |
|
RNA
|
Sale | 1,622 | Jan 21, 2025 | Jan. 23, 2025, 9:15 p.m. |
|
RNA
|
Sale | 11,151 | Dec 18, 2024 | Dec. 19, 2024, 7:16 p.m. |
|
RNA
|
Sale | 27,262 | Nov 06, 2024 | Nov. 8, 2024, 5:50 p.m. |
|
RNA
|
Sale | 65,182 | Nov 06, 2024 | Nov. 8, 2024, 5:50 p.m. |
|
RNA
|
Sale | 13,875 | Nov 06, 2024 | Nov. 8, 2024, 5:50 p.m. |
|
RNA
|
Sale | 11,510 | Sep 23, 2024 | Sept. 23, 2024, 8:59 p.m. |
|
RNA
|
Sale | 11,228 | Jun 18, 2024 | June 20, 2024, 6:48 p.m. |
|
RNA
|
Sale | 104,245 | Jun 12, 2024 | June 14, 2024, 7:07 p.m. |
|
RNA
|
Sale | 75,000 | May 14, 2024 | May 16, 2024, 6:25 p.m. |
|
RNA
|
Sale | 40,000 | Mar 13, 2024 | March 15, 2024, 4:12 p.m. |
|
RNA
|
Sale | 1,616 | Jan 22, 2024 | Jan. 23, 2024, 4:11 p.m. |
$RNA Executives and Stock Owners with Insider Trades
-
Sarah Boyce, President and CEO
-
Michael F Maclean, Chief Financial Officer
-
Teresa Mccarthy, Chief Human Resources Officer
-
Steven George Hughes, Chief Medical Officer
-
Arthur A Levin, Chief Scientific Officer
-
Kathleen P. Gallagher, Chief Program Officer
-
W. Michael Flanagan, CSTO
-
W. Michael Flanagan, Chief Scientific Officer
-
Eric Mosbrooker, Chief Commercial Officer
-
John B Moriarty, Chief Legal Officer
-
Charles Iii Calderaro, Chief Technical Officer
-
Roderick Wong, MP and CIO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.